Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.

What Do Studies Say?

The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.

The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.

The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.

The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

How Was The Study Conducted?

The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.

Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."

Why Does It Work So Well Against Alcoholism?

The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.

However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.

In a significant case, the Supreme Court has allowed the medical termination of pregnancy of a 15-year-old girl who was over seven months pregnant.

Stressing that the choice of the pregnant woman must remain paramount, the SC bench led by Justice B V Nagarathna and Ujjal Bhuyan observed that a woman cannot be compelled to continue with an unwanted pregnancy merely on the ground that the child can be given up for adoption after birth.

However, AIIMS has sought a review of the order, citing medical ethics and the rights of an unborn child. The institution stated that it would lead to preterm delivery of a deformed baby needing prolonged NICU support.

The apex Court also issued a warning to the Union government of contempt proceedings if it failed to comply with its order, making it clear that the procedure must be carried out without delay.

What Is The case?

The SC directed the termination of a fetus over seven months old of the 15-year-old girl, who was in a consensual relationship with a 17-year-old, admitted at AIIMS Delhi since April 10.

In India, medical abortion is allowed up to 20-24 weeks of pregnancy under the Medical Termination of Pregnancy (MTP) Act. However, in this case, the medical termination was allowed, giving primacy to the reproductive autonomy of the minor.

The Justices made it clear that “no court ought to compel any woman, and more so a minor child, to carry a pregnancy to full term against her express will.”

“If the pregnant woman carrying an unwanted pregnancy is compelled to continue such a pregnancy, then the constitutional rights of the pregnant woman would be breached,” noted the court.

Also read: Why Miscarriage Needs Emotional Care At Par with Medical Treatment: Doctors Explain

However, Solicitor General Tushar Mehta, appearing before the court, told the bench that the child could be given up for adoption through CARA after being born. He told the bench that, as per medical reports, termination of pregnancy at this stage may be risky for both the mother and the unborn child.

But Justice Nagarathna warned that denying relief in such circumstances could expose women, especially minors, to grave risks, including resort to unregulated procedures that may cause irreversible harm.

The court also underscored the minor’s psychological distress, including reported attempts to take her own life, observing that forcing continuation of the pregnancy would have “long-lasting repercussions” on her mental health, education, social standing, and overall development, Law Beat reported.

Directing that the procedure be carried out at AIIMS Delhi with all necessary medical safeguards, the court required the minor’s guardian to submit an undertaking consenting to the termination.

Why Is AIIMS Asking For A Review Of The SC Order?

AIIMS said the “unborn viable child” cannot speak for itself and depends on the court’s parens patriae jurisdiction to protect its right to life, The Times of India reported.

AIIMS, in its plea, said, “The court’s order proceeds on the premise of termination of pregnancy; however, the medical reality, as disclosed by the post-order assessment, is that a living, viable child will be prematurely delivered into the world.”

AIIMS also cited a fresh medical board opinion, saying the fetus is viable and preterm delivery could cause long-term disabilities and pose a grave risk to the minor mother. It said if the baby is carried to term, the state could care for it till adoption.

Referring to a similar case, AIIMS said a prematurely delivered baby continues to need NICU support, suffered repeated sepsis, and remains dependent on tracheostomy care.

Artificial Intelligence can fast-track better diagnostics, and even a cure for Alzheimer’s Disease, said OpenAI CEO Sam Altman.

In an exclusive interview with TODAY, Altman also announced that the OpenAI Foundation is pledging $100 million to Alzheimer’s research.

“AI has the potential to dramatically speed up how we discover treatments, improve diagnostics, and hopefully get us closer to a cure,” he said.

“This is one of the hardest problems in medicine - and one that affects millions of families. We felt we could help accelerate progress,” Altman added.

OpenAI Commits $100 Million For Alzheimer’s Research

Alzheimer's disease is one of the most common forms of dementia, causing 60-70 percent of cases. It mostly affects adults over the age of 65 and is a leading cause of death and disability.

In a statement, OpenAI noted that Alzheimer’s is "one of the toughest problems in medicine".

"AI’s ability to reason across complex data could help researchers uncover new insights," it added.

Also read: This Common Vaccine At Higher Dose Can More Than Halve Alzheimer’s Risk In Older Adults

The company will partner with six research institutions to

• support and accelerate Alzheimer’s research
• generating new data,
• helping design new drugs,
• expanding possible paths to treatment, including repurposing existing FDA-approved molecules.

“The OpenAI Foundation’s Alzheimer’s research initiative represents more than scientific progress. It’s a hope for millions of people, families, and anyone concerned about brain health. We applaud bold investments that prioritize speed and rigor, because every day matters. We must accelerate breakthroughs that change what it means to live with, or be at risk for, Alzheimer’s," said Joanne Pike, President and CEO of the Alzheimer’s Association.

What Is Alzheimer’s Disease?

Alzheimer's disease is believed to be caused by the development of toxic amyloid and beta proteins in the brain, which can accumulate in the brain and damage cells responsible for memory.

While there is no clear cause of Alzheimer's disease, experts believe it can develop due to genetic mutations and lifestyle choices, such as physical inactivity, unhealthy diet, and social isolation.

Read More: The One Critical Thing You Should Do To Prevent Alzheimer's Disease

Early symptoms of Alzheimer's disease include forgetting recent events or conversations. Over time, Alzheimer's disease leads to serious memory loss and affects a person's ability to do everyday tasks.

There is no cure for this progressive brain disorder, and in advanced stages, loss of brain function can cause dehydration, poor nutrition, or infection. These complications can result in death.

About 8.8 million Indians aged 60 and above are estimated to be living with Alzheimer's disease. Over seven million people in the US, 65 and older, live with the condition, and over 100,00 die from it annually.

South Carolina, which saw the largest measles outbreak in the United States in decades, has declared the outbreak over, state health officials announced.

The development comes as US cases reach 1,792, raising concerns about the country losing its measles elimination status achieved in 2000.

On Monday, health officials in South Carolina marked 42 days without new measles cases, confirming the outbreak that began in Spartanburg County last October has ended. There were nearly 1,000 confirmed cases over six months, including at least 21 hospitalizations.

On the upside, the outbreak led to a significant uptake in the measles, mumps, and rubella vaccinations. The state said 81,096 MMR vaccinations were given overall statewide, up 31.3 per cent from the previous year.

According to the public health experts, the increasing vaccination coverage played a significant role in helping to get the outbreak under control.

In a statement, South Carolina’s Department of Public Health’s Interim Agency Director, Edward Simmer, said that there was a 93.6 percent increase in MMR vaccinations during the outbreak.

The MMR vaccine is highly effective. One dose prevents the disease about 93 per cent of the time, and two doses raise that protection to 97 per cent.

“Vaccination – combined with other opportunities for good, solid public health work – really can be effective, even against some of the most contagious viruses,” said Dr. Brannon Traxler, deputy director and chief medical officer with the South Carolina Department of Public Health, CNN reported.

Notably, unvaccinated school-age children were the most affected by this outbreak, with 95.3 per cent of case-patients unvaccinated and 90.8 per cent of cases in children 17 years old and younger, CIDRAP news reported.

A total of 33 schools had measles exposures, and seven public school districts were affected. Over the course of six months, 874 students were asked to quarantine.

Also read: Robert F. Kennedy Jr. Denies Link To Measles Outbreak At Senate Hearing

US Measles Tally Nears 1,800

As per the Centers for Disease Control and Prevention's (CDC) latest weekly update, the US saw 44 new measles cases, one more than the 43 new cases confirmed the previous week. The national total now stands at 1,792 cases.

In 2026, 22 new outbreaks have been reported, and 93 per cent of confirmed cases are outbreak-associated. While there have been no deaths in 2026 from measles, six percent of case-patients (101 of 1,792) have been hospitalized this year in the US.

South Carolina also reported an additional measles case this month. However, it was determined not to be associated with the broader outbreak, but the single case exposed more than 40 people.

Utah reported five more cases in the past week, bringing the state total to 410 for 2026. Arizona has seven more cases, raising the 2026 total to 85. The four most recent cases came from Maricopa County.

“The re-emergence of measles in the Americas is a significant setback, but one that is entirely reversible and demands decisive action,” PAHO Director Jarbas Barbosa said in a press statement.

With several countries in the Americas, including Canada, Mexico, and the US, seeing a measles resurgence, the PAHO has urged leaders to increase MMR vaccination rates.

Also read: Surging Measles Cases In US Prompting Antivaxxers To Quietly Embrace MMR Vaccine: Report

What Is Measles?

Measles is a highly contagious virus that spreads through direct contact or through the air when an infected person coughs or sneezes. It is a vaccine-preventable disease that can cause devastating complications, including blindness, pneumonia, encephalitis, and long-term immune dysfunction.

Symptoms typically appear seven to 14 days after exposure and may include:

• high fever,
• cough,
• runny nose,
• red eyes,
• rashes across the body.